Treatment of psoriatic arthritis has tended to follow evidence-based strategies for achieving remission or minimal disease activity in rheumatoid arthritis. However, distinct immunopathogenic ...

Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.

and it reduces a person’s response to psoriatic arthritis treatments.e60dc2a1-f33c-4a05-9b50-8e3e8e597629035f8912-713d-4902-9125-fc63975f7049 How Is Psoriatic Arthritis Diagnosed? Diagnosis To ...

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more here.

The FDA today approved bimekizumab-bkzx (Bimzelx), an IL-17A and IL-17F inhibitor, for the treatment of adults with active psoriatic arthritis, those with active nonradiographic axial ...

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, ...

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

Symptoms of psoriatic arthritis are similar to rheumatoid arthritis and include, pain, swelling and stiffness in one or more ...

Essentially, he was asking what makes RA different from the type of arthritis that you usually hear about: osteoarthritis.

should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be considered in treatment targets.